CHICAGO — Management of thyroid eye disease requires a carefully planned, personalized approach, according to Michael Kazim, MD, speaking at the American Academy of Ophthalmology meeting.
“In the acute phase, I never treat patients surgically, with the exception of those who don’t tolerate medicines or don’t respond to them,” he said.
In the chronic phase, when patients have had at least 6 months of stable thyroid eye disease and have not improved spontaneously, the classic surgical interventions are decompression followed by strabismus surgery and lid surgery.